Digital therapeutic (DTX) companies are moving away from their branding as standalone treatments, or prescription digital therapeutics (PDTs), and toward status as a complement to traditional medicines and a way to expand access to care.
DTX Companies Find New Niche As Complement To Standard Of Care
Digital therapeutics aren’t going away anytime soon, but they are positioning themselves as a complement to traditional therapies.
